Employees Retirement System of Texas Takes Position in ICON PLC (ICLR)
Employees Retirement System of Texas acquired a new stake in ICON PLC (NASDAQ:ICLR) during the second quarter, according to its most recent disclosure with the SEC. The institutional investor acquired 32,000 shares of the medical research company’s stock, valued at approximately $3,129,000. Employees Retirement System of Texas owned about 0.06% of ICON PLC as of its most recent filing with the SEC.
Several other large investors have also recently bought and sold shares of ICLR. Shine Investment Advisory Services Inc. bought a new stake in shares of ICON PLC in the 2nd quarter valued at $103,000. Acrospire Investment Management LLC boosted its stake in shares of ICON PLC by 20.1% in the 2nd quarter. Acrospire Investment Management LLC now owns 1,195 shares of the medical research company’s stock valued at $117,000 after purchasing an additional 200 shares during the last quarter. Parallel Advisors LLC boosted its stake in shares of ICON PLC by 20.7% in the 2nd quarter. Parallel Advisors LLC now owns 1,265 shares of the medical research company’s stock valued at $133,000 after purchasing an additional 217 shares during the last quarter. US Bancorp DE boosted its stake in shares of ICON PLC by 15.0% in the 1st quarter. US Bancorp DE now owns 1,929 shares of the medical research company’s stock valued at $154,000 after purchasing an additional 251 shares during the last quarter. Finally, Huntington National Bank boosted its stake in shares of ICON PLC by 5.0% in the 2nd quarter. Huntington National Bank now owns 1,630 shares of the medical research company’s stock valued at $159,000 after purchasing an additional 77 shares during the last quarter. 91.53% of the stock is currently owned by institutional investors.
TRADEMARK VIOLATION WARNING: “Employees Retirement System of Texas Takes Position in ICON PLC (ICLR)” was first published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this story on another website, it was illegally stolen and reposted in violation of US and international copyright legislation. The correct version of this story can be accessed at https://www.thecerbatgem.com/2017/10/09/employees-retirement-system-of-texas-takes-position-in-icon-plc-iclr.html.
ICON PLC (NASDAQ:ICLR) opened at 113.63 on Monday. The company’s 50 day moving average is $111.91 and its 200-day moving average is $96.78. The firm has a market cap of $6.14 billion, a P/E ratio of 23.05 and a beta of 0.59. ICON PLC has a 52-week low of $73.76 and a 52-week high of $117.53.
ICON PLC (NASDAQ:ICLR) last issued its earnings results on Thursday, July 27th. The medical research company reported $1.31 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.30 by $0.01. ICON PLC had a net margin of 15.97% and a return on equity of 28.72%. The firm had revenue of $431.00 million for the quarter, compared to analysts’ expectations of $430.68 million. During the same quarter last year, the business earned $1.14 earnings per share. The business’s revenue was up 5.0% on a year-over-year basis. On average, equities analysts predict that ICON PLC will post $5.32 EPS for the current fiscal year.
A number of equities research analysts have recently commented on the stock. Zacks Investment Research lowered shares of ICON PLC from a “buy” rating to a “hold” rating in a research note on Thursday, September 7th. Jefferies Group LLC reaffirmed a “buy” rating and issued a $122.00 price objective on shares of ICON PLC in a research note on Tuesday, September 12th. Bank of America Corporation assumed coverage on shares of ICON PLC in a research note on Monday, September 11th. They issued a “buy” rating and a $128.00 price objective on the stock. Finally, ValuEngine raised shares of ICON PLC from a “hold” rating to a “buy” rating in a research note on Friday, September 1st. One investment analyst has rated the stock with a sell rating, three have given a hold rating, seven have given a buy rating and two have given a strong buy rating to the company. ICON PLC has a consensus rating of “Buy” and a consensus price target of $113.00.
About ICON PLC
ICON public limited company is a contract research organization (CRO), which is engaged in providing outsourced development services to the pharmaceutical, biotechnology and medical device industries. The Company is engaged in the strategic development, management and analysis of programs that support the various stages of the clinical development process, from compound selection to Phase I-IV clinical studies.
Receive News & Stock Ratings for ICON PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICON PLC and related stocks with our FREE daily email newsletter.